BioSig Technologies: Funding, Investors & Team (Sep 2026)
At BioSig, we're working to develop and deliver the advanced signal processing solutions that will unlock the future of bioelectronic medicine, starting with the PURE EP™ System. They built BioSig to achieve this vision – with a strong commitment to research, a world-class leadership team, and a network of expert partners.
BioSig Technologies has raised $6.5M across 2 funding rounds on record, the most recent a Post-IPO Equity of $3.5M announced in Jun 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioSig Technologies Company Profile and Key Stats
Latest funding round on record: Jun 2022.
BioSig Technologies Funding Rounds
BioSig Technologies raised $3.0M in a Post-IPO Equity announced in Mar 2022.
3 months later, a Post-IPO Equity of $3.5M was announced in Jun 2022.
BioSig Technologies Founders and Leadership Team
No contact details are on record for this team yet.
BioSig Technologies Funding Compared to Other Biotechnology Startups
BioSig Technologies' latest round of $3.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioSig Technologies in Biotechnology and Westport
Companies Similar to BioSig Technologies
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
BioSig Technologies Funding FAQs
What does BioSig Technologies do?
At BioSig, we're working to develop and deliver the advanced signal processing solutions that will unlock the future of bioelectronic medicine, starting with the PURE EP™ System. They built BioSig to achieve this vision – with a strong commitment to research, a world-class leadership team, and a network of expert partners.
How much funding has BioSig Technologies raised?
BioSig Technologies has raised $6.5M across 2 rounds on record. The most recent is a Post-IPO Equity of $3.5M announced in Jun 2022.
When did BioSig Technologies last raise funding?
BioSig Technologies' most recent funding round on record is a Post-IPO Equity of $3.5M, announced in Jun 2022.
Who is the CEO of BioSig Technologies?
Ken Londoner is listed as CEO at BioSig Technologies.
Where is BioSig Technologies headquartered?
BioSig Technologies is based in Westport, Connecticut, United States.
How many employees does BioSig Technologies have?
BioSig Technologies is in the 51-100 employee band.
How does BioSig Technologies' funding compare to other Biotechnology startups?
BioSig Technologies' latest round of $3.5M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's BioSig Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioSig Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.